These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2677123)

  • 1. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis.
    Veldhuyzen van Zanten SJ; Tytgat KM; Jalali S; Goodacre RL; Hunt RH
    J Clin Gastroenterol; 1989 Oct; 11(5):496-501. PubMed ID: 2677123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.
    Mertens JC; Dekker W; Ligtvoet EE; Blok P
    Antimicrob Agents Chemother; 1989 Feb; 33(2):256-7. PubMed ID: 2719469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
    Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
    Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].
    Koop H
    Z Gastroenterol; 1989 Nov; 27(11):701-2. PubMed ID: 2694657
    [No Abstract]   [Full Text] [Related]  

  • 6. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
    Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
    Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter pylori-associated gastritis. Is antibiotic therapy now justified?
    Talley NJ
    J Clin Gastroenterol; 1988 Feb; 10(1):10-2. PubMed ID: 3356873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter pylori and non-ulcer dyspepsia.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Am J Gastroenterol; 1987 Nov; 82(11):1149-52. PubMed ID: 3673994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ulcer dyspepsia and Campylobacter pylori gastritis: to treat or not to treat?
    Talley NJ
    Med J Aust; 1987 Nov; 147(9):471-2. PubMed ID: 3670207
    [No Abstract]   [Full Text] [Related]  

  • 10. Campylobacter pylori--a role in non-ulcer dyspepsia?
    Lambert JR; Dunn K; Borromeo M; Korman MG; Hansky J
    Scand J Gastroenterol Suppl; 1989; 160():7-13. PubMed ID: 2683024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
    Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
    Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonulcer dyspepsia: association with chronic Helicobacter pylori infection-related gastritis?
    Ching CK; Lam SK
    J Clin Gastroenterol; 1995; 21 Suppl 1():S140-5. PubMed ID: 8775007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter pylori. An advance in understanding of dyspepsia and gastritis.
    Colin-Jones DG
    J Clin Gastroenterol; 1989; 11 Suppl 1():S39-42. PubMed ID: 2809137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.
    Berstad A; Alexander B; Weberg R; Serck-Hanssen A; Holland S; Hirschowitz BI
    Gastroenterology; 1988 Sep; 95(3):619-24. PubMed ID: 3294081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter gastritis and associated disorders.
    Hendrix TR; Yardley JH
    South Med J; 1988 Jul; 81(7):859-62. PubMed ID: 3293234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of Campylobacter pylori gastritis: a study of symptomatic nonulcer dyspepsia and bile gastritis.
    Tewari SN; Cerezo L; Price G
    J Clin Gastroenterol; 1989 Jun; 11(3):271-7. PubMed ID: 2787819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
    Moayyedi P; Deeks J; Talley NJ; Delaney B; Forman D
    Am J Gastroenterol; 2003 Dec; 98(12):2621-6. PubMed ID: 14687807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Gut; 1988 Oct; 29(10):1386-91. PubMed ID: 3058555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.